What are the benefits of the anti-FGF23 antibody burosumab on the manifestations of X-linked hypophosphatemia in adults in comparison with conventional therapy? A review

X-linked hypophosphatemia (XLH) is a genetic disease mostly related to PHEX gene mutations which increases FGF23 serum levels, leading to hypophosphatemia and osteomalacia in adults, while affected children, in addition, develop rickets. Most of adults with XLH suffer from reduced quality of life an...

Descripción completa

Detalles Bibliográficos
Autor principal: Lafage-Proust, Marie-Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032432/
https://www.ncbi.nlm.nih.gov/pubmed/37180412
http://dx.doi.org/10.1177/26330040221074702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032432/
https://www.ncbi.nlm.nih.gov/pubmed/37180412
http://dx.doi.org/10.1177/26330040221074702

Ejemplares similares